Drug Clinical Trials List

Study Title	Study Sponsor	Status	Study Drug	Trial Phase	Study Protocol Number	Site
Prospective Multicentre Observational Registry Of Treatments And Outcomes In Patients With Chronic	Astellas Pharma International	Ongoing	N/A	4	ONC-MA1002	Aseer Central Hospital
Efficacy of Different Mouthwashes in the Reduction of Halitosis: A Randomized, Double Blind, Placebo-Controlled, Crossover Clinical Trial	King Abdulaziz City for Science and Technology (KACST)	Ongoing	Halita - AO ProRinse	4	PR oo39	College of Dentistry King Saud University
Observational Prospective STudy In Management of 1st line KRAS Wildtype mCRC with Erbitux™ (Cetuximab)- OPTIM1SE	Merck Serono	Ongoing	Erbitux (Cetuximab)	4	EMR062202-561	King Fahad Medical City (Riyadh), King Abdulaziz Medical City NG (Riyadh), Prince Sultan Military Medical City (Riyadh), King Fahad Specialist Hospital (Dammam)
easypod connect: A regional, Multicentre, Observational study to evaluate Adherenceand Long Term Outcomes of Therapy in Paediatric subjects using “easypodTM” electromechanical device for growth hormone treatment	Merck Serono	Ongoing	N/A	4	EMR200104-534	King Fahad University Hospital (Al-Khobar), alhabib
AWARE-AMAC (A World-wide Antihistamine-Refractory chronic urticaria patient Evaluation in Asia pacific, Middle-east and African Countries (AWARE-AMAC): A noninterventional study to collect data on the management and clinical impacts of chronic urticaria in patients refractory to H1-antihistamine therapy	Novartis	Ongoing	N/A	4	E3401	King Abdulaziz University Hospital (Jeddah), King Fahad Specialist Hospital (Dammam), King Faisal Specialist Hospital and Research Center (Riyadh), King Faisal Specialist Hospital and Research Center (Jeddah)
Postoperative Analgesic Effect ofDexmedetomidine as an Adjunct to Ropivacaine Administration in Wound Infiltration for Modified Radical Mastectomy- A Randomized controlled Trial	King Abdullah Medical City, Makkah	Ongoing	DEXMEDETOMIDINE	2	14-119	King Abdullah Medical City (Makkah)
CogniPlus Study assessing Cognitive performance plus Physical activity in patients with Relapsing-Remitting MS under treatment with Betaferon®	Bayer	Ongoing	Betaferon	4	16036	King Fahad Hospital (Madinah), Security Forces Hospital (Riyadh), Aseer Central Hospital, King Khalid University Hospital (Riyadh), Al-Noor Specialist Hospital (Makkah), King Abdul Aziz Specialist hospital (Taif), King Fahad Specialist Hospital (Dammam)
Non transfusion dependent Thalassemia Drug Registry	Novartis	Ongoing	Exjade (Deferasirox)	4	E2422	King Abdulaziz University Hospital (Jeddah), King Abdulaziz Medical City NG (Jeddah), King Khalid University Hospital (Riyadh)
A Phase III randomized, double-blind, placebo-controlled study of LEE011 or placebo in combination with tamoxifen and goserelin or a non-steroidal aromatase inhibitor (NSAI) and goserelin for the treatment of premenopausal women with hormone receptor positive, HER2-negative, advanced breast cancer	Novartis	Ongoing	LEE011 (Ribociclib)	3	CLEE011E2301	King Khalid University Hospital (Riyadh)_ King Faisal Specialist Hospital and Research Center (Riyadh)
International Registry to assess mEdical Practice withlOngitudinal obseRvation for Treatment of Heart Failure(REPORT-HF)	Novartis	Ongoing	N/A	4	2401	King Fahad Specialist Hospital (Dammam)